Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Oncology Practice
|
September 22, 2010
Collaboration between cooperative groups and industry
Linda R Bressler, Richard L Schilsky
Cancer Chemotherapy and Pharmacology
|
April 9, 2013
Bevacizumab and central nervous system (CNS) hemorrhage
Nathalie Letarte, Linda R Bressler, John L Villano
Cancer Chemotherapy and Pharmacology
|
December 8, 2011
Going past the data for temozolomide
J Lee Villano, Nathalie Letarte, Linda R Bressler
Cancer Chemotherapy and Pharmacology
|
June 23, 2009
Temozolomide in malignant gliomas: current use and future targets
J Lee Villano, Tara E Seery, Linda R Bressler
Cancer Chemotherapy and Pharmacology
|
May 27, 2011
Hematologic adverse events associated with temozolomide
J Lee Villano, Nathalie Letarte, Janny M Yu, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 20, 2009
Understanding and managing the possible adverse effects associated with bevacizumab
Stacy S Shord, Linda R Bressler, Lauryn A Tierney, et al.
The Annals of Pharmacotherapy
|
February 6, 2009
Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose
Stacy S Shord, Linda R Bressler, Latha Radhakrishnan, et al.
Journal of Neuro-Oncology
|
July 17, 2014
Analyzing temozolomide medication errors: potentially fatal
Nathalie Letarte, Michael P Gabay, Linda R Bressler, et al.
Clinical Trials (London, England)
|
July 5, 2022
Landscape of coronavirus disease 2019 clinical trials: New frontiers and challenges
Susan Halabi, Jinyi Zhou, Yijie He, et al.
CNS Drugs
|
November 14, 2015
Oral Targeted Therapies and Central Nervous System (CNS) Metastases
Michael P Gabay, Scott M Wirth, Joan M Stachnik, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Oncology Practice
|
September 22, 2010
Collaboration between cooperative groups and industry
Linda R Bressler, Richard L Schilsky
Cancer Chemotherapy and Pharmacology
|
April 9, 2013
Bevacizumab and central nervous system (CNS) hemorrhage
Nathalie Letarte, Linda R Bressler, John L Villano
Cancer Chemotherapy and Pharmacology
|
December 8, 2011
Going past the data for temozolomide
J Lee Villano, Nathalie Letarte, Linda R Bressler
Cancer Chemotherapy and Pharmacology
|
June 23, 2009
Temozolomide in malignant gliomas: current use and future targets
J Lee Villano, Tara E Seery, Linda R Bressler
Cancer Chemotherapy and Pharmacology
|
May 27, 2011
Hematologic adverse events associated with temozolomide
J Lee Villano, Nathalie Letarte, Janny M Yu, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 20, 2009
Understanding and managing the possible adverse effects associated with bevacizumab
Stacy S Shord, Linda R Bressler, Lauryn A Tierney, et al.
The Annals of Pharmacotherapy
|
February 6, 2009
Evaluation of the Modified Diet in Renal Disease equation for calculation of carboplatin dose
Stacy S Shord, Linda R Bressler, Latha Radhakrishnan, et al.
Journal of Neuro-Oncology
|
July 17, 2014
Analyzing temozolomide medication errors: potentially fatal
Nathalie Letarte, Michael P Gabay, Linda R Bressler, et al.
Clinical Trials (London, England)
|
July 5, 2022
Landscape of coronavirus disease 2019 clinical trials: New frontiers and challenges
Susan Halabi, Jinyi Zhou, Yijie He, et al.
CNS Drugs
|
November 14, 2015
Oral Targeted Therapies and Central Nervous System (CNS) Metastases
Michael P Gabay, Scott M Wirth, Joan M Stachnik, et al.
Page
of 2